Evaluation of the effect of newer antioxidant lycopene in the treatment of oral submucous fibrosis

Reactive oxygen compounds or free radicals have been implicated as one of the major harmful factors for premalignant and malignant conditions. Present study concludes that lycopene, a newer antioxidant, appears to be a very promising drug in the management of OSMF.